Integra LifeSciences Holdings Corporation IART
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 102.63% | 98.55% | -1,612.25% | -7,337.70% | -7,468.14% |
| Total Depreciation and Amortization | -2.55% | -1.29% | 3.77% | 7.76% | 24.30% |
| Total Amortization of Deferred Charges | -31.62% | -27.70% | -6.54% | 0.21% | 6.47% |
| Total Other Non-Cash Items | -99.08% | -103.79% | 4,156.72% | 2,025.76% | 2,149.17% |
| Change in Net Operating Assets | -14.93% | 6.79% | -22.89% | -8.80% | -240.26% |
| Cash from Operations | 57.21% | 20.37% | -30.21% | -61.06% | -35.00% |
| Capital Expenditure | 41.79% | 45.04% | 42.85% | 22.01% | 5.57% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 101.48% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -497.82% | -253.84% | -185.63% | -210.37% | 119.59% |
| Cash from Investing | -33.43% | -50.42% | 76.66% | 72.35% | 82.56% |
| Total Debt Issued | -79.40% | 485.78% | 317.14% | 48.14% | 50.52% |
| Total Debt Repaid | 77.87% | -520.89% | -268.57% | -257.98% | -298.37% |
| Issuance of Common Stock | -20.59% | -20.59% | -20.59% | -85.04% | -85.55% |
| Repurchase of Common Stock | 64.25% | 64.09% | 96.08% | 94.79% | 89.96% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 64.42% | 63.92% | -23.36% | -72.06% | -66.73% |
| Cash from Financing | -358.25% | 268.21% | 101.47% | -88.09% | -101.33% |
| Foreign Exchange rate Adjustments | -131.05% | -110.55% | 296.20% | 378.73% | -14.59% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 17.89% | -230.66% | 99.35% | 62.28% | 129.07% |